COVID-19 Update

COVID-19 has imposed an unsettling situation upon our community and our business, but at Cleveland Diabetes Care and our affiliates, KRS Global Biotechnology and Complete Pharmacy Medical Solutions, we are committed to fighting back the best way we know how. By providing better medicine for better lives we will continue operations that include creation and distribution of life saving medications and testing kits to all reaches of our great nation.

KRS Global Blog

Synergistic Approach to Serialization And The Drug Quality & Security Act

Hang around pharmaceutical drug manufacturers long enough and the conversation
will undoubtedly turn to the global dilemma of safeguarding the public from the
proliferation of counterfeit drugs, and the Drug Quality and Security Act (DQSA). Now
a law, the DQSA includes a phased timeline, extending to 2023, that requires U.S.
prescription drug manufacturers to comply with a unified federal mandate regarding
transaction history and serialization. While the law eliminates the “wait-and-see”
attitude some manufacturers had taken, applying a synergistic approach to the forced
system and procedural updates can garner overwhelming benefits.

See entire paper here